Kids Library Home

Welcome to the Kids' Library!

Search for books, movies, music, magazines, and more.

     
Available items only
Print Material
Corporate Author United States. Congress. House. Committee on Oversight and Accountability, author.

Title Oversight and reauthorization of the Office of National Drug Control Policy : hearing before the Committee on Oversight and Accountability, House of Representatives, One Hundred Eighteenth Congress, first session, July 27, 2023.

Publication Info. Washington : U.S. Government Publishing Office, 2023.

Copies

Description 1 online resource (iii, 57 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Note In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
Associated bill citation(s): H.R. 920.
"Serial no. 118-55."
Bibliography Includes bibliographical references.
Performer Hearing witnesses: Dr. Rahul Gupta, Director, Office of National Drug Control Policy.
Event Date of hearing: 2023-07-27.
Note Description based on online resource; title from PDF title page (GovInfo, viewed Oct. 3, 2023).
Subject United States. Office of National Drug Control Policy -- Evaluation.
United States. Office of National Drug Control Policy. (OCoLC)fst00648079
Drug control -- United States.
Drug traffic -- United States -- Prevention.
Lutte antidrogue -- États-Unis.
Crime and Law Enforcement.
Government Operations and Politics.
Drug control. (OCoLC)fst01032891
Evaluation. (OCoLC)fst00916975
United States. (OCoLC)fst01204155
Genre/Form Legislative hearings. (OCoLC)fst01910825
Legislative hearings.
Audiences législatives.
Other Form: Print version: United States. Congress. House. Committee on Oversight and Accountability. Oversight and reauthorization of the Office of National Drug Control Policy (OCoLC)1399536920
Standard No. 53-024 (GPO jacket number)
Gpo Item No. 1016-E (online)
Sudoc No. Y 4.OV 2:118-55

 
    
Available items only